XML 59 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Consolidated Revenues Generated by Unaffiliated Customers (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Pharma Services Company A [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 19.00% 14.00%
Pharma Services Company B [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 12.00% [1]
Discontinued Operations Determa Rx [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 55.00% 65.00%
[1] Less than 10%